Risk-Based Audits Import Alert 66-40 Explained: How One Data Integrity Finding Can Block Your Entire Supply Chain for 18 Months Read More » July 2, 2026 No Comments
Risk-Based Audits The FDA Just Issued Its First Warning Letter for AI Misuse in CGMP Documentation: Here’s What Happened Read More » June 30, 2026 No Comments
GVP Audits GDP Compliance for Cold Chain Logistics: Updated Requirements and Audit Checklist Read More » June 25, 2026 No Comments
Pharmacovigilance Services The New EU Pharmaceutical Legislation 2026: What Changes for Pharmacovigilance? Read More » June 23, 2026 No Comments
Pharma Audits FDA Draft Guidance on Responding to Form 483 Observations: A Practical Guide for CGMP Sites Read More » June 18, 2026 No Comments
Pharmacovigilance Services FDA’s New Overseas Inspection Approach: What Pharma Sites Need to Know Read More » June 16, 2026 No Comments
Pharmacovigilance Services EMA and FDA Issue Joint Principles on AI in Medicine Development: What It Means for PV Teams Read More » June 11, 2026 No Comments
Pharma Audits GDP 2026: Understanding MHRA, DSCSA, and Global Traceability Requirements Read More » June 9, 2026 No Comments
GVP Audits Root Cause Analysis Tools for GxP CAPA: When to Use Ishikawa, 5-Why and Fault Tree Analysis Read More » June 4, 2026 No Comments
Pharma Audits PSMF Maintenance Checklist: What Needs Updating After a Licence Variation, Product Transfer or MAH Change Read More » June 2, 2026 No Comments